Dogwood Therapeutics

Dogwood Therapeutics Dogwood Therapeutics is a development-stage biotechnology company focused on advancing novel therapeutics for pain and fatigue illness.

New watershed moment for Nav 1.7 and Nav 1.8 inhibitors
07/07/2025

New watershed moment for Nav 1.7 and Nav 1.8 inhibitors

The success of Vertex’s opioid alternative Journavx could aid a group of biotechs that aim to take a similar development path with NaV1.8 and NaV1.7 inhibitors.

Long Covid Knocked a Million Americans Off Their Career PathsYears after infection, even answering email remains arduous...
08/26/2024

Long Covid Knocked a Million Americans Off Their Career Paths
Years after infection, even answering email remains arduous for many

Years after infection, even answering email remains arduous for many.

06/20/2024

Virios Therapeutics is pleased that Maxim Group, LLC has initiated research coverage with its first research report authored by analyst Jason McCarthy. Note: Analyst research is conducted independently of the company, and Virios does not endorse or adopt the views expressed in any analyst research report.

Brain Fog from Long Covid after 9 months shares gene signatures with acute infections.Future focus should be on antivira...
05/17/2024

Brain Fog from Long Covid after 9 months shares gene signatures with acute infections.
Future focus should be on antiviral medicine and not rehab or brain training.
50% LC still experiencing brain fog at 2 years.

Long COVID is associated with active inflammatory changes in the nervous system, but the condition is distinct from Alzheimer's disease and other neurodegenerative disorders, according to a Rutgers Health study.

Many employers have a long Covid problem, making it more challenging to hire and retain employees and to support their p...
05/13/2024

Many employers have a long Covid problem, making it more challenging to hire and retain employees and to support their productivity.
 In 2022, economics professors at Harvard University, estimated that long Covid costs the U.S. economy between $160 billion and $200 billion per year in lost wages and increased medical costs.
 In 2023, the Brookings Institution reported that 700,000 people were absent from the U.S. labor force due to the illness.
 The adults with Long Covid that are still working, may work fewer hours, or struggle with tasks that used to be easy for them, or both.
 In 2024, 6.9% of U.S. adults — 17.8 million people — have long Covid

Nearly 18 million U.S. adults have long Covid, a multisystem illness that sometimes appears after a bout of Covid-19. Its wide range of symptoms vary from person to person, veer from mild to severe, and can wax and wane over time. There are no official treatments for long Covid; while some people se...

03/21/2024

Address

44 Milton Avenue
Alpharetta, GA
30009

Alerts

Be the first to know and let us send you an email when Dogwood Therapeutics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Dogwood Therapeutics:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram